These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 17556068

  • 1. Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions.
    Herry A, Douet-Guilbert N, Morel F, Le Bris MJ, Morice P, Abgrall JF, Berthou C, De Braekeleer M.
    Cancer Genet Cytogenet; 2007 Jun; 175(2):125-31. PubMed ID: 17556068
    [Abstract] [Full Text] [Related]

  • 2. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A, Douet-Guilbert N, Morel F, Le Bris MJ, De Braekeleer M.
    Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
    [Abstract] [Full Text] [Related]

  • 3. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M, Hélias C, Struski S, Perrusson N, Uettwiller F, Mozziconacci MJ, Lafage-Pochitaloff M, Dastugue N, Terré C, Brizard F, Cornillet-Lefebvre P, Mugneret F, Barin C, Herry A, Luquet I, Desangles F, Michaux L, Verellen-Dumoulin C, Perrot C, Van den Akker J, Lespinasse J, Eclache V, Berger R, Groupe Francophone de Cytogénétique Hématologique.
    Cancer Genet Cytogenet; 2007 Jul 01; 176(1):1-21. PubMed ID: 17574959
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Submicroscopic deletions in 5q- associated malignancies.
    Crescenzi B, La Starza R, Romoli S, Beacci D, Matteucci C, Barba G, Aventin A, Marynen P, Ciolli S, Nozzoli C, Martelli MF, Mecucci C.
    Haematologica; 2004 Mar 01; 89(3):281-5. PubMed ID: 15020265
    [Abstract] [Full Text] [Related]

  • 10. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M, Arenillas L, Espinet B, Salido M, Hernández JM, Lumbreras E, del Rey M, Arranz E, Ramiro S, Font P, González O, Renedo M, Cervera J, Such E, Sanz GF, Luño E, Sanzo C, González M, Calasanz MJ, Mayans J, García-Ballesteros C, Amigo V, Collado R, Oliver I, Carbonell F, Bureo E, Insunza A, Yañez L, Muruzabal MJ, Gómez-Beltrán E, Andreu R, León P, Gómez V, Sanz A, Casasola N, Moreno E, Alegre A, Martín ML, Pedro C, Serrano S, Florensa L, Solé F.
    Haematologica; 2008 Jul 01; 93(7):1001-8. PubMed ID: 18591625
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q.
    Gao Q, Horwitz M, Roulston D, Hagos F, Zhao N, Freireich EJ, Golomb HM, Olopade OI.
    Genes Chromosomes Cancer; 2000 Jun 01; 28(2):164-72. PubMed ID: 10825001
    [Abstract] [Full Text] [Related]

  • 12. Fluorescence in situ hybridization for del(5q) in myelodysplasia/acute myeloid leukemia: comparison of EGR1 vs. CSF1R probes and diagnostic yield over metaphase cytogenetics alone.
    Sun Y, Cook JR.
    Leuk Res; 2010 Mar 01; 34(3):340-3. PubMed ID: 19608274
    [Abstract] [Full Text] [Related]

  • 13. Role of multiplex FISH in identifying chromosome involvement in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes: a report on 28 cases.
    Barouk-Simonet E, Soenen-Cornu V, Roumier C, Cosson A, Laï JL, Fenaux P, Preudhomme C.
    Cancer Genet Cytogenet; 2005 Mar 01; 157(2):118-26. PubMed ID: 15721632
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O, Hofmann WK, Baldus CD, Thiel G, Serbent V, Schümann E, Thiel E, Blau IW.
    Exp Hematol; 2007 Feb 01; 35(2):221-9. PubMed ID: 17258071
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?
    Galván AB, Mallo M, Arenillas L, Salido M, Espinet B, Pedro C, Florensa L, Serrano S, Solé F.
    Leuk Res; 2010 Sep 01; 34(9):1242-5. PubMed ID: 20362335
    [Abstract] [Full Text] [Related]

  • 18. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J, Zemanová Z, Ransdorfová S, Pavlistová L, Babická L, Housková L, Melichercíková J, Sisková M, Cermák J, Michalová K.
    Cancer Genet Cytogenet; 2007 Feb 01; 173(1):10-6. PubMed ID: 17284364
    [Abstract] [Full Text] [Related]

  • 19. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S, Kohlmann A, Schnittger S, Kern W, Haferlach T, Haferlach C.
    Genes Chromosomes Cancer; 2014 May 01; 53(5):402-10. PubMed ID: 24493299
    [Abstract] [Full Text] [Related]

  • 20. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
    Chen L, Li J, Zhu Y, Qiu H, Pan J, Wang R, Qian S, Xu W, Xue Y.
    Exp Oncol; 2007 Dec 01; 29(4):299-303. PubMed ID: 18199987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.